上岡博 (Hiroshi Ueoka) - マイポータル - researchmap

基本情報

所属: 旧所属岡山大学大学院医歯薬学総合研究科血液・腫瘍・呼吸器内科学助教授

学位: 医学博士

J-GLOBAL ID: 200901084336101775
researchmap会員ID: 1000035105

研究キーワード

4

研究分野

2

学歴

2

- 1975年

岡山大学, 医学部, 医学科
- 1975年

岡山大学

委員歴

7

MISC

56

Phase I/II study of docetaxel and cisplatin with concurrent thoracic radiation therapy for locally advanced non-small-cell lung cancer

K Kiura, H Ueoka, Y Segawa, M Tabata, H Kamei, N Takigawa, S Hiraki, Y Watanabe, A Bessho, K Eguchi …

BRITISH JOURNAL OF CANCER 89(5) 795-802 2003年9月
Phase I/II study of altered schedule of cisplatin and etoposide administration and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-stage small-cell lung cancer

Y Segawa, H Ueoka, K Kiura, M Tabata, N Takigawa, Y Hiraki, Y Watanabe, T Yonei, T Moritaka, J Hiyama …

LUNG CANCER 41(1) 13-20 2003年7月
Dramatic effect of ZD1839 (ﾔIressaﾕ) in a patient with advanced non-small-cell lung cancer and poor performance status

Lung Cancer 40(1) 73-76 2003年4月
Prognostic significance of mutant p53 protein, p-glycoprotein and glutathione S-transferase-p in patients with unresectable non-small-cell lung cancer

Anticancer Research 23, 2837-2844 2003年
Fractionated administration o firinotecan and cisplatin for treatment of extensive disease small-cell lung cancer: A phase II study

Anticancer Research 23, 557-560 2003年
Preoperative induction chemotherapy with cisplatin and irinotecan for pathological N2 non-small cell lung cancer

H. Date, K. Kiura, H. Ueoka, M. Tabata, M. Aoe, A. Andou, T. Shibayama, N. Shimizu

British Journal of Cancer 86(4) 530-533 2002年2月12日
Daily Low-Dose Cisplatin and Concurrent Thoracic Irradiation for Poor-Risk Patients with Unresectable Non-Small-Cell Lung Cancer

Acta Medica Okayama 56, 261-266 2002年
Risk of neutropenic fever and early infectious complications after autologous peripheral blood stem cell transplantation for malignant diseases

International Journal of Heamatology 76, 186-191 2002年
Gingival metastasis in lung cancer

Oncology Report 9, 571-574 2002年
Comparison of chemosensitivity test: Clonogenic assay versus MTT assay

Acta Medica Okayama 56, 129-134 2002年
A phase III randomized trial comparing vindesine and cisplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer: long-term follow-up results and analysis of prognostic factors

Lung Cancer 36, 313-319 2002年
Interleukin-12 augments cytolytic activity of peripheral blood mononuclear cell against autologous lung cancer cells in combination with IL-2

Lung Cancer 35, 329-333 2002年
Characterization of non-small-cell lung cancer cell lines established before and after chemotherapy

Lung Cancer 35, 305-314 2002年
Polymorphisms of UDP-glucurnosyltransferase and pharmacokinetics of irinotecan

Therapeutic Drug Monitoring 24, 111-116 2002年
Parathyroed gormone-related protein measured at first visit is on indicator for bone nutostases and survioal in lung cancer patients with hypescelcemia

Cancer 95 1706-1713 2002年
A case-control study of lung cancer screening in Okayama Prefecture, Japan

K Nishii, H Ueoka, K Kiura, T Kodani, M Tabata, T Shibayama, K Gemba, T Kitajima, A Hiraki, M Kawaraya …

LUNG CANCER 34(3) 325-332 2001年12月
Synergistic effect of topoisomerase I inhibitor, 7-ethyl-10-hydroxycamptothecin, and irradiation in a cisplatin-resistant human small-cell lung cancer cell line

Clinical Cancer Research 8, 287-292 2001年
Generation of cytotoxic T lymphocytes against autologous lung cancer cells resistant to apoptosis

Anticancer Research 21, 2561-2567 2001年
Fraotionated administration o irinotecan and cisplatin for treatment of non-small-cell long cancer:A pheseⅡ study of layama hung caner study Groap

Brit J Cancer 85 9-13 2001年
Pro-gastrin-releasing peptide(Pro GRP)and neunon specific enolase (NSE) have a complementary role for each other in diagnosis and prognosis of small-cell lung cancer

Lung Cancer 32(1) 61-69 2001年

もっとみる

所属学協会

13

共同研究・競争的資金等の研究課題

2